Atossa genetics inc

Major-Pharmaceuticals

ATOS


107 Spring Street
Seattle , WA 98104

Executive/
Director

Price

  • Last Close
  • $ 1.36
    $ -0.02 -1.45 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.14 - $0.63
  • YTD
  • 54.5%

  • Trading Volume
  • 16,923
  • Market Cap Full
  • $ 170.4M
  • Shares Outstanding
  • 125.3M
    Nov 8, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 25.9% 7.5% -46.1% 69.3% 245.1% -5% 122.1% -23.6% 37.1% 104.6%
Q2 -37.2% -18.6% -34.2% -54.1% -31.5% 4% 199.5% -12.8% 73.8% -8%
Q3 -31.9% -50% 6% -20.8% -17.8% 8% -48.1% -23.9% -41.5% -
Q4 -58.4% -32.9% -51.2% -37.8% -22.7% -60.7% -50.2% -36.3% 23.1% -
J F M A M J J A S O N D
2024 -3% 14.4% 84.2% 2.2% - - - - - - - -
2023 51.4% -7.6% -2% -11.9% 45.5% 35.5% -12.7% -28.2% -6.7% -9.1% 10.9% 18.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -38%-78%-71%-81%-68%55%-40%72%-68%66%55%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.13 0.07 0.45 -0.71 -0.62 -0.32 -0.04 -0.04 -0.05
Q2 0.11 0.05 0.64 -5.08 -0.8 -0.43 -0.06 -0.05 -0.08
Q3 0.15 0.07 0.17 -0.64 -0.36 -0.34 -0.04 -0.06 -0.05
Q4 - 0.77 - 0.93 -0.25 -0.88 -0.04 -0.06 -
A 0.4 1 1.3 -5.5 -2 -1.97 -0.2 -0.21 -0.18

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 9.1 9.1 120.8 126.6 126.6
Jun 2.7 9.1 9.2 120.8 126.6 126.6
Sep 5.1 9.1 10.4 126.6 126.6 125.8
Dec 5.6 9.1 10.5 126.6 126.6 125.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 28 - -5 - -
Equity multiplier 0.1 - - - -